Carlo Di Mario
Declaration of interest
| Function | Company |
|---|---|
| Grants/research support | Abbott Vascular |
| Grants/research support | Medtronic |
| Grants/research support | Micell |
| Consultant | St. Jude Medical |
| Honorarium | Biosensors International |
| Honorarium | Cordis Cardiac & Vascular Institute |
| Honorarium | Eli Lilly |
Latest contributions
Global momentum of Shockwave intravascular lithotripsy: evidence, experience and evolution
11 Dec 2025 – From GulfPCR-GIM 2025
This session examines the growing global experience in the treatment of calcified coronary lesions, bringing together updated clinical evidence and real-world practice.
Recent data are discussed alongside insights from high-volume operators to show how calcium modification strategies are evolving and being integrated into contemporary PCI workflows.
By combining...
DES and DCB for bifurcation treatment
21 May 2025 – From EuroPCR 2025
Examine the use of drug-eluting stents (DES) and drug-coated balloons (DCB) in bifurcation lesion treatment. This session compares devices, analyses DAPT duration, and evaluates side branch optimization to inform best practices in bifurcation PCI.
DCB-PCI in de novo lesions
20 May 2025 – From EuroPCR 2025
Evaluate the role of drug-coated balloon (DCB) angioplasty in de novo coronary lesions with a focus on vessel diameter effects, comparisons to drug-eluting stents for small non-complex lesions, management of unstented dissections, high bleeding risk scenarios, and optimal dual antiplatelet therapy durations.
Hemodynamic support during CTO PCI: to use it or not?
15 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 Clinical Case submissions focused on the use of hemodynamic support devices during percutaneous coronary interventions (PCI) for chronic total occlusions (CTO). Experts will present and discuss challenging cases where the use of devices like the Impella pump or pulsatile left...
Treatment strategies in complex coronary
14 May 2024 – From EuroPCR 2024
This session comprises a selection of complex coronary intervention cases from the EuroPCR 2024 Clinical Case submissions. The cases cover a range of challenging scenarios, including CTO with left ventricular dysfunction and VT storm, subintimal tracking and re-entry, and the decision between native vessel CTO PCI...
Decision-making based on intracoronary imaging in CTO-PCI
17 May 2023 – From EuroPCR 2023
Join this session dedicated to "Advancing Percutaneous Coronary Intervention for Chronic Total Occlusion". Explore the latest advances, evidence-based practices and transformative techniques that leverage intracoronary imaging to improve decision-making in percutaneous coronary intervention for chronic total occlusion. Be inspired by leading experts and collaborate with other...
More pulses to take you further across all calcium morphologies
17 May 2023 – From EuroPCR 2023
Discover the latest insights on intravascular lithotripsy (IVL) for treating calcified lesions: explore its mechanism of action, technological advancements, and practical tips for challenging cases, including diffuse lesions, left main bifurcations, and eccentric/calcified nodules. Enhance your expertise in IVL with this concise and informative session!
Cracking calcium: intravascular lithotripsy’s unique mode of action in treating calcified lesions – What's the evidence?
14 Dec 2022 – From GulfPCR-GIM 2022
Watch this GulfPCR-GIM 2022 session to understand the unique mechanism of action of IVL, the use of intravascular imaging in calcium identification, the gender gap, disrupted CAD trials, and the evolution of treatment of calcified lesions together with the role of IVL.
Role of OCT in multivessel PCI
18 May 2022 – From EuroPCR 2022
How would you treat a 67-year-old male patient with dyslipidemia and family history of CAD, referred for coronary angiography because of severe, significant silent myocardial ischemia? Watch this LIVE case from Toulouse, France, to find out what your peers' choices are.
Conquer calcium with intravascular lithotripsy (IVL): cases and clinical data
18 May 2022 – From EuroPCR 2022
This EuroPCR 2022 session mainly focuses on the DISRUPT CAD studies: hear discussion on the latest DISRUPT CAD clinical evidence supporting the use of IVL across different calcium morphologies, appraise the most recent one-year OCT-pooled analysis of the DISRUPT CAD III and IV studies, and learn about the differences...
Challenging coronary case: anatomical complexity on top of a CTO
17 May 2022 – From EuroPCR 2022
Consult this session to discover a selection of complex coronary cases, such as: CTO of ostial left anterior descending, with affectation of ostial circumflex, left main bifurcation lesion with CTO of LAD, and more!
Intravascular lithotripsy: expanding the boundaries of transfemoral TAVI
21 Nov 2021 – From PCR London Valves 2021
Join Sam Dawkins, Ole De Backer and Carlo Di Mario to learn about the latest news regarding intravascular lithotripsy and how it may impact the future of transfemoral TAVI.
The rising wave: new intravascular lithotripsy publications
18 May 2021 – From EuroPCR 2021
Watch this session presented by Benjamin Honton, James Spratt, Ziad Ali, Carlo Di Mario and Jonathan Hill in order to learn of the latest in Intravascular Lithotripsy (IVL) publications, to understand its mechanism of action, and to identify its clinical utility.
